Zurvita Holdings, Inc.

Zurvita Holdings, Inc. markets health and wellness products in the United States, Hong Kong, Canada, Singapore, Australia, the United Kingdom, and the Dominican Republic. Its principal products comprise Zeal Wellness, an antioxidants and vitamins nutritional product in wild berry and bold grape flavors; Zeal Advanced Formula Protein Shakes, a source of dietary fiber in chocolate delight and vanilla crème flavors; Zeal cleanse, a herbal and probiotic cleanse; and Zeal burn, a thermogenic fat burner. The company sells its products through its network of independent sales consultants. Zurvita Holdings, Inc. is headquartered in Houston, Texas. Zurvita Holdings, Inc. is a subsidiary of The Amacore Group, Inc.

Zurvita Holdings, Inc. trades as ZRVT on OTC. The company is classified in Consumer Defensive / Household & Personal Products and reports in USD.

The current profile places the business in Household & Personal Products. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Zurvita Holdings, Inc. can be compared against peers such as Avenir Wellness Solutions, Inc., Education Management Corporation, Grand Havana, Inc., Happy Town Holdings Inc., Iconic Brands, Inc., Kimberly Parry Organics Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $13,032, beta of -1.36, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ZRVT currently shows total debt of N/A and beta of -1.36. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.zurvita.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.